HLB Pharmaceutical Co. Ltd (047920) — Long-term Investment Intensity
HLB Pharmaceutical Co. Ltd (047920) has a Long-term Investment Intensity of 3.1% as of September 2019. Long-term investments of ₩1.11 Billion represent 3.1% of total assets of ₩36.49 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 047920 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
HLB Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2018)
This chart shows how HLB Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 3.1%, reflecting long-term investments of ₩1.11 Billion against total assets of ₩36.49 Billion KRW. For the complete balance sheet picture, see HLB Pharmaceutical Co. Ltd total assets.
Annual Long-term Investment Intensity for HLB Pharmaceutical Co. Ltd (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for HLB Pharmaceutical Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 047920 total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 3.5% | ₩1.26 Billion | ₩36.42 Billion | ▼ -1.0 pp |
| 2017 | 4.5% | ₩1.79 Billion | ₩39.85 Billion | ▼ -2.9 pp |
| 2016 | 7.4% | ₩3.05 Billion | ₩41.24 Billion | ▲ +5.1 pp |
| 2015 | 2.3% | ₩559.47 Million | ₩24.85 Billion | ▲ +0.5 pp |
| 2014 | 1.8% | ₩377.50 Million | ₩21.43 Billion | — |